All lobbying filings

BRIDGEBIO PHARMA, INC.

Lobbying for BRIDGEBIO PHARMA, INC. · Biotech company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $500,000.00 expenses · posted Jul 20, 2026

Official filing document

Bills named in this filing 2

HR 1532
Scientific EXPERT Act of 2025
S 822
Scientific EXPERT Act of 2025

Lobbying activity 1

Pharmacy

Orphan drug policies General issues and provisions related to PBM Reform General issues and provisions related to tariffs H.R.1532 and S.822 - Scientific EXPERT Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.